A panel of public health experts from California, Nevada, Oregon and Washington was meeting to discuss potentially lifting the pause on the Johnson & Johnson vaccine, a spokesman for the California Department of Public Health said Saturday.
Meanwhile, Los Angeles County public health officials went ahead with telling vaccine providers they could resume administering Johnson & Johnson doses on Saturday, if they give out an updated fact sheet about the vaccine to recipients.
Dr. Paul Simon, chief science officer for the county’s Department of Public Health, said the county has been working on developing additional materials to explain the rare blood clotting issue that prompted the J&J vaccine pause on April 13.
Those will “include what we think is really important information about what to look for--the signs and symptoms if you were to have this, again, very rare reaction,” he said. “And we are going to underscore that this is a very rare reaction.”
